Systemic AAV9 Human Propionyl-CoA Carboxylase, Alpha Subunit (AAV9-hPCCA) Gene Therapy Provides Direct and Sustained Therapeutic Benefits in the Treatment of Propionic Acidemia: From Animal Model to Orphan Drug Designation (ODD)
MOLECULAR THERAPY（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined